Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) SHH

55.53

+5.05(+10.00%)

Updated at September 08 03:00PM

Currency In CNY

Valuation

Market Cap11.91B
Enterprise Value10.54B
P/E Ratio16.65
PEG Ratio-17.32
Price/Sales Ratio5.86
Price/Book Ratio3.98
Enterprise/Revenue5.35
Enterprise/EBITDA13.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.35
Operating Margin0.39

Management Effectiveness

Return On Assets0.18
Return On Equity0.25

Income Statement

Revenue2.81B
Revenue/Share8.87
Gross Profit2.64B
EBITDA1.24B
Net Income1.05B
Diluted EPS3.26

Balance Sheet

Total Cash3.03B
Total Cash/Share9.44
Total Debt692.66M
Total Debt/Equity0.17
Current Ratio2.94
Book Value Per Share13.09

Price History

52-Week Change57.08
52-Week High52.88
52-Week Low31.3
Moving Average 50 Days42.5
Moving Average 200 Days38.03

Statistics

Average Volume9.92M
Shares Outstanding322.32M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.87
Trailing Annual Dividend Yield3.62
Payout Ratio0.64
Last Split Factor13:10
Last Split DateApril 30, 2024